Uncategorized Archives - Page 83 of 232

MondayNov 25, 2019 4:00 pm

FDA Wants More Scientific Data During CBD Regulation Making Process

Players in the cannabidiol (CBD) sector will have to sit tight and wait after the U.S. Food and Drug Administration (FDA) announced that it needs more scientific data before issuing a regulatory framework for the rapidly growing industry. The sector got a new breath of life after the 2018 Hemp Farming Act removed industrial hemp from the list of controlled substances, paving the way for farmers in all 50 states to plant the cash crop. In the year since hemp cultivation became legal, the market has been flooded with thousands of untested and unregulated products, each claiming to cure certain…

MondayNov 25, 2019 9:00 am

Florida Poll Reveals Overwhelming Support for Cannabidiol Research

Cannabidiol (CBD), the cannabis extract that has been referred to as a 'miracle drug' by some has been all the rage over the past few years. Said to be effective against a variety of medical conditions, the compound has been subject to great interest. The 2018 Hemp Farming Act catalyzed the sector's growth, allowing farmers to grow industrial hemp under state programs and inevitably, leading to an influx of suppliers, each looking to cash in on the insanely popular cash crop. The industry's growth has been so fast that it has outpaced regulators, leaving them scrambling to create some sort…

FridayNov 22, 2019 4:00 pm

Awareness of CBD Grows in Europe

Cannabidiol (CBD) is probably one of the most popular topics in the West at the moment. The hemp extract has garnered intense interest, especially in Europe and the U.S., with more people aware of the cannabinoid and its perceived medical benefits. Said to have potent and versatile medicinal properties, CBD has been found effective against a wide variety of medical conditions ranging from high blood pressure and anxiety to chronic pain and even cancer. But as is expected of a sector that has seen massive growth over such a short period, there has been limited research and public education on…

FridayNov 22, 2019 9:00 am

NY Activists Vow to Improve Stalled CBD and Hemp Bill

The 2018 Hemp Farming Act was a godsend for the hemp industry. The legislation classified cannabis with less than 0.3 percent THC as hemp and removed it from its list of controlled substances. Dubbed by some as a catalyst for explosive growth, the bill gave farmers in all 50 states leeway to grow the versatile cash crop under regulation. Six months later in June 2019, the New York Assembly passed the state's own Hemp Extract Bill. The bill would have allowed licensed retailers to add up to 20mg of CBD per twelve ounces beverage. However, several months later, the bill…

ThursdayNov 21, 2019 4:00 pm

Mother Shares Story of Son’s Miraculous Cure After Taking CBD

Cannabidiol is without a doubt the breakout star among medicines this decade, if not the century. The cannabis extract is a darling of the medicine, sports, and the health and wellness communities, with potent and versatile medicinal properties that make it effective against a wide range of diseases. A lot of people use it for pain and anxiety relief, but anecdotally, CBD has worked against high blood pressure, improved sleep and reduced seizures in people with epilepsy. In June 2018, the FDA approved a CBD-based medication to help manage seizures in rare forms of childhood epilepsy. Recently the UK National…

ThursdayNov 21, 2019 12:55 pm

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Eyes Opportunity to Provide Biosynthetic Cannabinoids in Market with Explosive Potential

Willow’s plan to provide biosynthetic cannabinoid has potential to disrupt the cannabis-industry supply chain Biosynthetically derived cannabinoids offer unique advantages related to reliability, scalability, quality and cost Key collaboration allows company to capitalize on enormous market opportunity Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, believes that the cannabis industry presents an exciting opportunity for the well-positioned company. As the market anticipates the legalization of cannabis-derivative products in Canada, and the CBD legal landscape continues to change rapidly in the United States and around the world, cannabinoids are appearing as…

ThursdayNov 21, 2019 11:36 am

ChineseInvestors.com Inc. (CIIX) CEO Describes Tremendous Opportunity in CBD-Cosmetics to China’s Market of 1.4 Billion Consumers

CIIX anticipates launch of hemp-infused wrinkle cream in China Through subsidiary CBD Biotech, CIIX will focus hemp and CBD products on the blooming Chinese market The company noted impressive sales, revenue growth for Q1 2020, greatly due to success of CBD Biotech ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang noted the enormous potential for cosmetics infused with industrial hemp in a RedChip Money Report interview. This sentiment was echoed in his letter to shareholders, where he noted that CBD-infused cosmetics will the company and its subsidiary, CBD Biotech, to a Chinese market of 1.4 billion people. CIIX plans to launch…

ThursdayNov 21, 2019 9:00 am

CBD Christmas Pudding Now Available in the UK

Very few products can claim to have achieved the kind of fame cannabidiol has in the short time it has been mainstream. The US CBD market alone was estimated to be $1.3 billion in 2018, and it is expected to hit $23 billion by 2025. The compound is a potent and versatile medicine, and it has been found effective against a range of medical conditions from anxiety and high blood pressure to chronic pain. UK lifestyle retailer Firebox is looking to cash in on the CBD craze through a completely novel and unique idea; CBD Christmas pudding. The £9.99 ($12.9)…

WednesdayNov 20, 2019 4:00 pm

Company Teams Up With Florida State University to Study Painkilling Effects of CBD

CBD, or cannabidiol, as the nerds call it is a hemp extract that has completely taken the world by storm. The compound is said to be effective against a variety of medical conditions, ranging from insomnia to chronic pain and high blood pressure. In June 2018, the FDA approved a CBD-based drug to treat epilepsy-related seizures in children. 14% of all Americans use CBD, and roughly 40% of these users do it for pain relief. Arguably, there has been a lot of interest in cannabidiol's anti-inflammatory properties, especially as an alternative to opiates. A leading hemp research company is looking…

WednesdayNov 20, 2019 1:46 pm

MCTC Holdings Inc. (MCTC) Advances Cannabinoid Delivery Research Efforts, Files Fourth High-Tech Patent

Most significant patent filed is also the most comprehensive, covering broad areas of cannabinoid polymeric nanoparticles and fibers Company is committed to continuing research program and expand its intellectual property portfolio over the coming months MCTC participating in multiple growing verticals within global cannabis industry through acquisitions, strategic partnerships, and intellectual property MCTC Holdings Inc. (OTC: MCTC), a cannabinoid science innovator focused on high-growth and high-margins sub-sectors of the cannabis and hemp industry, filed its fourth cannabinoid delivery technology patent. The patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially…